{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T01:37:39Z","timestamp":1794879459319,"version":"4.9.1"},"reference-count":20,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Otolaryngol Head Neck Surg"],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Whether F18-choline (FCH) positron emission tomographic (PET)\/computed tomographic (CT) scan can replace Tc99m-sestaMIBI (MIBI) single-photon emission (SPE)CT\/CT as a first-line imaging technique for preoperative localization of parathyroid adenomas (PTA) in patients with primary hyperparathyroidism (PHPT) is unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare first-line FCH PET\/CT vs MIBI SPECT\/CT for optimal care in patients with PHPT needing parathyroidectomy and to compare the proportions of patients in whom the first-line imaging method resulted in successful minimally invasive parathyroidectomy (MIP) and normalization of calcemia 1 month after surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>A French multicenter randomized open diagnostic intervention phase 3 trial was conducted. Patients were enrolled from November 2019 to May 2022 and participated up to 6 months after surgery. The study included adults with PHPT and an indication for surgical treatment. Patients with previous parathyroid surgery or multiple endocrine neoplasia type 1 (MEN1) were ineligible.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Patients were assigned in a 1:1 ratio to receive first-line FCH PET\/CT (FCH1) or MIBI SPECT\/CT (MIBI1). In the event of negative or inconclusive first-line imaging, they received second-line FCH PET\/CT (FCH2) after MIBI1 or MIBI SPECT\/CT (MIBI2) after FCH1. All patients underwent surgery under general anesthesia within 12 weeks following the last imaging. Clinical and biologic (serum calcemia and parathyroid hormone levels) assessments were performed 1 and 6 months after surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was a true-positive first-line imaging-guided MIP combined with uncorrected serum calcium levels of 2.55 mmol\/l or less 1 month after surgery, corresponding to the local upper limit of normality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 57 patients received FCH1 (n\u2009=\u200929) or MIBI1 (n\u2009=\u200928). The mean (SD) age of patients was 62.8 (12.5) years with 15 male (26%) and 42 female (74%) patients. Baseline patient characteristics were similar between groups. Normocalcemia at 1 month after positive first-line imaging-guided MIP was observed in 23 of 27 patients (85%) in the FCH1 group and 14 of 25 patients (56%) in the MIBI1 group. Sensitivity was 82% (95% CI, 62%-93%) and 63% (95% CI, 42%-80%) for FCH1 and MIBI1, respectively. Follow-up at 6 months with biochemical measures was available in 43 patients, confirming that all patients with normocalcemia at 1 month after surgery still had it at 6 months. No adverse events related to imaging and 4 adverse events related to surgery were reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This randomized clinical trial found that first-line FCH PET\/CT is a suitable and safe replacement for MIBI SPECT\/CT. FCH PET\/CT leads more patients with PHPT to correct imaging-guided MIP and normocalcemia than MIBI SPECT\/CT thanks to its superior sensitivity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT04040946\">NCT04040946<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaoto.2024.1421","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T11:04:57Z","timestamp":1718881497000},"page":"658","source":"Crossref","is-referenced-by-count":41,"title":["F18-Choline PET\/CT or MIBI SPECT\/CT in the Surgical Management of Primary Hyperparathyroidism"],"prefix":"10.1001","volume":"150","author":[{"given":"Elske","family":"Quak","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine and Thyroid Unit, Centre Fran\u00e7ois Baclesse, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Lasne-Cardon","sequence":"additional","affiliation":[{"name":"Department of Head & Neck Surgery, Centre Fran\u00e7ois Baclesse, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Cavarec","sequence":"additional","affiliation":[{"name":"Department of Head & Neck Surgery, University Hospital of Caen, Caen France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Lireux","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Thyroid Unit, Centre Fran\u00e7ois Baclesse, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vianney","family":"Bastit","sequence":"additional","affiliation":[{"name":"Department of Head & Neck Surgery, Centre Fran\u00e7ois Baclesse, Caen, France"},{"name":"Department of Head & Neck Surgery, University Hospital of Caen, Caen France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Roudaut","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University Hospital of Brest, Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Salaun","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital of Brest, Brest, France"},{"name":"EA 3878, University of Bretagne Occidentale, Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Keromnes","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital of Brest, Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebl","family":"Potard","sequence":"additional","affiliation":[{"name":"Department of Head & Neck Surgery, University Hospital of Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Vaduva","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University Hospital of Rennes, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle","family":"Esvant","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University Hospital of Rennes, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Jegoux","sequence":"additional","affiliation":[{"name":"ENT Department, Rennes University Medical Center, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"de Crouy-Chanel","sequence":"additional","affiliation":[{"name":"ENT Department, Rennes University Medical Center, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Devillers","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Eugene Marquis Cancer Institute, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Guery","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Eugene Marquis Cancer Institute, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charline","family":"Lasnon","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Thyroid Unit, Centre Fran\u00e7ois Baclesse, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Ciappuccini","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Thyroid Unit, Centre Fran\u00e7ois Baclesse, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9r\u00e9nice","family":"Legrand","sequence":"additional","affiliation":[{"name":"Clinical Research Department, Centre Fran\u00e7ois Baclesse, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Estienne","sequence":"additional","affiliation":[{"name":"Clinical Research Department, Centre Fran\u00e7ois Baclesse, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Christy","sequence":"additional","affiliation":[{"name":"Clinical Research Department, Centre Fran\u00e7ois Baclesse, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Grellard","sequence":"additional","affiliation":[{"name":"Clinical Research Department, Centre Fran\u00e7ois Baclesse, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Bardet","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Thyroid Unit, Centre Fran\u00e7ois Baclesse, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Clarisse","sequence":"additional","affiliation":[{"name":"Clinical Research Department, Centre Fran\u00e7ois Baclesse, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"ooi240034r1","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/SLA.0b013e318208fed9","article-title":"The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism.","volume":"253","author":"Udelsman","year":"2011","journal-title":"Ann Surg"},{"key":"ooi240034r2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.yasu.2012.04.004","article-title":"Superiority of minimally invasive parathyroidectomy.","volume":"46","author":"Kunstman","year":"2012","journal-title":"Adv Surg"},{"issue":"10","key":"ooi240034r3","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1007\/s00259-018-3980-9","article-title":"18F-Fluorocholine PET\/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT\/CT: a prospective dual-centre study in 100 patients.","volume":"45","author":"Beheshti","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"ooi240034r4","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.2967\/jnumed.121.261900","article-title":"Diagnostic performances of cervical ultrasound, sestamibi scintigraphy and contrast-enhanced (18)F-fluorocholine positron emission tomography in primary hyperparathyroidism.","volume":"63","author":"Boudousq","year":"2021","journal-title":"J Nucl Med"},{"issue":"4","key":"ooi240034r5","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/s00259-017-3911-1","article-title":"F18-choline PET\/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT\/CT are negative or inconclusive: the APACH1 study.","volume":"45","author":"Quak","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"ooi240034r6","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s00259-014-2837-0","article-title":"18F-Fluorocholine PET\/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study.","volume":"41","author":"Lezaic","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"ooi240034r7","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2967\/jnumed.119.229914","article-title":"18F-Fluorocholine PET\/CT in primary hyperparathyroidism: superior diagnostic performance to conventional scintigraphic imaging for localization of hyperfunctioning parathyroid glands.","volume":"61","author":"Cuderman","year":"2020","journal-title":"J Nucl Med"},{"issue":"9","key":"ooi240034r8","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.2967\/jnumed.120.257303","article-title":"Assessment and comparison of 18F-fluorocholine PET and 99mTc-sestamibi scans in identifying parathyroid adenomas: a metaanalysis.","volume":"62","author":"Whitman","year":"2021","journal-title":"J Nucl Med"},{"issue":"8","key":"ooi240034r9","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1001\/jamaoto.2021.0915","article-title":"Direct comparison of preoperative imaging modalities for localization of primary hyperparathyroidism: a systematic review and network meta-analysis.","volume":"147","author":"Lee","year":"2021","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"14","key":"ooi240034r10","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ab2a22","article-title":"Performance evaluation of quantitative SPECT\/CT using NEMA NU 2 PET methodology.","volume":"64","author":"Ryu","year":"2019","journal-title":"Phys Med Biol"},{"issue":"1","key":"ooi240034r11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1088\/1361-6498\/aaa86f","article-title":"18F-choline PET\/CT for parathyroid scintigraphy: significantly lower radiation exposure of patients in comparison to conventional nuclear medicine imaging approaches.","volume":"38","author":"Rep","year":"2018","journal-title":"J Radiol Prot"},{"issue":"1","key":"ooi240034r12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12902-020-00667-5","article-title":"Upfront F18-choline PET\/CT versus Tc99m-sestaMIBI SPECT\/CT guided surgery in primary hyperparathyroidism: the randomized phase III diagnostic trial APACH2.","volume":"21","author":"Quak","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"ooi240034r13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1741-7015-8-18","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials.","volume":"8","author":"Schulz","year":"2010","journal-title":"BMC Med"},{"issue":"2","key":"ooi240034r14","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1245\/s10434-011-1870-5","article-title":"A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism.","volume":"19","author":"Cheung","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"ooi240034r15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/001316446002000104","article-title":"A coefficient of agreement for nominal scales.","volume":"20","author":"Cohen","year":"1960","journal-title":"Educ Psychol Meas"},{"key":"ooi240034r16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/1745-6215-13-137","article-title":"Diagnostic randomized controlled trials: the final frontier.","volume":"13","author":"Rodger","year":"2012","journal-title":"Trials"},{"issue":"1","key":"ooi240034r17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13550-019-0544-3","article-title":"Parathyroid imaging with 18F-fluorocholine PET\/CT as a first-line imaging modality in primary hyperparathyroidism: a retrospective cohort study.","volume":"9","author":"Broos","year":"2019","journal-title":"EJNMMI Res"},{"issue":"2","key":"ooi240034r18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.23736\/S1824-4785.23.03512-4","article-title":"Detection, resection and cure: a systematic review and meta-analysis of 18F-choline PET in primary hyperparathyroidism.","volume":"67","author":"Quak","year":"2023","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"2","key":"ooi240034r19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/MNM.0000000000000952","article-title":"Choline PET\/CT in parathyroid imaging: a systematic review.","volume":"40","author":"Broos","year":"2019","journal-title":"Nucl Med Commun"},{"issue":"3","key":"ooi240034r20","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00405-017-4836-9","article-title":"Elevated parathyroid hormone levels after successful parathyroidectomy for primary hyperparathyroidism: a clinical review.","volume":"275","author":"de la Plaza Llamas","year":"2018","journal-title":"Eur Arch Otorhinolaryngol"}],"container-title":["JAMA Otolaryngology\u2013Head &amp; Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/articlepdf\/2819697\/jamaotolaryngology_quak_2024_oi_240034_1722952902.02761.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T11:10:05Z","timestamp":1723115405000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/fullarticle\/2819697"}},"subtitle":["A Diagnostic Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoto.2024.1421","relation":{},"ISSN":["2168-6181"],"issn-type":[{"value":"2168-6181","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,1]]}}}